National Drinking Water Database
National Drinking Water Database - Chemical Contaminants
Aldrin
Status: Unregulated - EPA has not established a maximum legal limit in tapwater for this contaminant.
Aldrin is a banned insecticide and termiticide previously used for field, forage, vegetable and fruit crops, primarily on corn and cotton; it was also used as a wood preservative.
Detected |
Found above health guidelines |
Found above legal limit |
|
|---|---|---|---|
| States | 8 |
8 |
- |
| Water utilities | 9 |
9 |
- |
| People Served | 268,773 |
268,773 |
- |
Health Concerns for Aldrin:
- Cancer
- Neurotoxicity
- Persistence and bioaccumulation
- Endocrine disruption
- Developmental/reproductive toxicity
- Occupational hazards
- Organ system toxicity (non-reproductive)
- Ecotoxicology
Aldrin Exposure by State
Water utilities in 8 states have reported detecting Aldrin in treated tap water since 2004, according to EWG's analysis of water quality data supplied by state water agencies.
| State | Water Suppliers with Aldrin contamination | Water suppliers reporting Aldrin above health-based limits | ||
|---|---|---|---|---|
| Systems | Population | Systems | Population | |
| Delaware | 1 | 201,000 | 1 | 201,000 |
| Nebraska | 2 | 49,889 | 2 | 49,889 |
| Massachusetts | 1 | 9,500 | 1 | 9,500 |
| Missouri | 1 | 3,500 | 1 | 3,500 |
| California | 1 | 3,300 | 1 | 3,300 |
| New York | 1 | 800 | 1 | 800 |
| North Carolina | 1 | 600 | 1 | 600 |
| Maryland | 1 | 184 | 1 | 184 |
| Total | 9 | 268,773 | 9 | 268,773 |
The Most Polluted Communities
9 water utilities reported detecting Aldrin in tap water since 2004, according to EWG's analysis of water quality data supplied by state water agencies
Ranked by highest average Aldrin level
| Rank | System | Population Served | Positive test results of total reported tests | Average Level (Range) |
|---|---|---|---|---|
| 1 | Borrego Wd Vista, CA | 3,300 | 1 of 1 | 94 ppb (94 ppb) |
| 2 | Luke / Newpage Luke Mill Luke, MD | 184 | 3 of 11 | 0.05 ppb (0 to 0.2 ppb) |
| 3 | Camelot S/D Garner, NC | 600 | 1 of 16 | 0.01 ppb (0 to 0.23 ppb) |
| 4 | Mcwa, Genesee West Rochester, NY | 800 | 1 of 4 | 0.01 ppb (0 to 0.04 ppb) |
| 5 | City of North Platte North Platte, NE | 25,000 | 1 of 30 | < 0.01 ppb (0 to 0.17 ppb) |
| 6 | Hopkinton Water Department Hopkinton, MA | 9,500 | 1 of 4 | < 0.01 ppb (0 to 0.02 ppb) |
| 7 | City of Kearney Kearney, NE | 24,889 | 1 of 35 | < 0.01 ppb (0 to 0.1 ppb) |
| 8 | Artesian Water Company Newark, DE | 201,000 | 1 of 83 | < 0.01 ppb (0 to 0.02 ppb) |
| 9 | Jefferson Co Pwsd # 8 Cedar Hill, MO | 3,500 | 1 of 2 | < 0.01 ppb (< .01 to 5.0E-5 ppb) |
Health Based Limits for Aldrin
| Standard | Description | Level |
|---|---|---|
| EPA Human Health Water Quality Criteria | Water quality criteria set by the US EPA provide guidance for states and tribes authorized to establish water quality standards under the Clean Water Act (CWA) to protect human health. These are non-enforceable standards based upon exposure by both drinking water and the contribution of water contamination to other consumed foods. Source: U.S. Environmental Protection Agency. | <0.01 ppb |
| One in one million (10-6) Cancer Risk | The concentration of a chemical in drinking water corresponding to an excess estimated lifetime cancer risk of 1 in 1,000,000. Source: U.S. Environmental Protection Agency. | <0.01 ppb |
| Health-Based Screening Level | A benchmark concentration of contaminants in water that may be of potential concern for human health, if exceeded. For noncarcinogens, the HBSL represents the contaminant concentration in drinking water that is not expected to cause any adverse effects over a lifetime of exposure. For carcinogens, the HBSL range represents the contaminant concentration in drinking water that corresponds to an excess estimated lifetime cancer risk of 1 chance in 1 million to 1 chance in 10 thousand. Source: U.S. Geological Survey. | <0.01 ppb-0.2 ppb |
| One in ten thousand (10-4) Cancer Risk | The concentration of a chemical in drinking water corresponding to an excess estimated lifetime cancer risk of 1 in 10,000. Source: U.S. Environmental Protection Agency. | 0.2 ppb |
| Children's health-based limit for 1-day exposure | Concentration of a chemical in drinking water that is not expected to cause any adverse, noncarcinogenic health effects for up to one day of exposure. The One-Day health-based limit (or Health Advisory, HA) is typically set to protect a 10-kg child consuming 1 liter of water per day. Source: U.S. Environmental Protection Agency. | 0.3 ppb |
| Children's health-based limit for 10-day exposure | Concentration of a chemical in drinking water that is not expected to cause any adverse, noncarcinogenic effects for up to ten days of exposure. The Ten-Day health-based limit (or Health Advisory, HA) is typically set to protect a 10-kg child consuming 1 liter of water per day. Source: U.S. Environmental Protection Agency. | 0.3 ppb |
| Drinking Water Equivalent Level | A lifetime exposure concentration protective of adverse, noncarcinogenic health effects, that assumes all of the exposure to a contaminant is from drinking water. Source: U.S. Environmental Protection Agency. | 1 ppb |
Testing Summary for Aldrin
| Are tests routinely required for Aldrin by federal law? | No |
| Water suppliers reporting tests for Aldrin (2004-2009): | 13,904 of 47,576 |
| Average testing rate for water supplier reporting tests (2004-2009): | 0.4 per year |
Cancer
| Type of concern: | Reference: |
| Possible human carcinogen | EPA Integrated Risk Information System (IRIS) |
| Possible human carcinogen | California EPA Proposition 65 |
| Cancer - strong evidence | Proposition 65 List of Carcinogens |
| Limited evidence of carcinogenicity | European Union - Classification & Labelling |
| Limited evidence of carcinogenicity | Amer Conf of Gov't Industrial Hygienists - Carcinogens |
| Limited evidence of carcinogenicity | NIOSH Occupational Carcinogens |
| Cancer - moderate evidence - immune system | CHE Toxicant and Disease Database |
| Cancer - limited evidence | CHE Toxicant and Disease Database |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Mutation Research 1977 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Archives of Toxicology 1980 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Mutation Research 1975 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Pharmacology and Therapeutics 1979 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Personal Communication from J 1982 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Carcinogenesis (London) 1987 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Mutation Research 1995 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- IRCS Medical Science 1986 |
| One or more in vitro tests non-mammalian cells show positive mutation results | RTECS®- Rivista di Scienza e Technologia degli Alimenti e di Nutrizione Umana 1976 |
| One or more in vitro tests on microorganisms show positive mutation results | RTECS®- Nucleus (Calcutta) 1985 |
| Cancer - not classifiable/not likely to be human carcinogen | Int'l Agency for Research on Cancer (IARC) - Carcinogens |
Neurotoxicity
| Type of concern: | Reference: |
| Strong evidence of human neurotoxicity | Chemicals known to be neurotoxic to humans |
Persistence and bioaccumulation
| Type of concern: | Reference: |
| Persistent, bioaccumulative in wildlife and humans | National Library of Medicine HazMap |
| Persistent, bioaccumulative in wildlife and humans | United Nations Environment Programme/POPs Treaty |
| Persistent, bioaccumulative in wildlife and humans | EPA Toxic Release Inventory PBTs |
| Persistent, bioaccumulative in wildlife | National Library of Medicine HazMap |
| Persistent, bioaccumulative in wildlife | Great Lakes BTS (Binational Toxics Strategy) PBTs |
| Persistent, bioaccumulative in wildlife | OSPAR PBTs - Substances of Possible Concern |
Endocrine disruption
| Type of concern: | Reference: |
| Human disruptor - moderate evidence | European Commission on Endocrine Disruption |
| Limited evidence of wildlife and the environment disruption | European Commission on Endocrine Disruption |
| Limited evidence of endocrine disruption | Illinois EPA, 1997 |
| endocrine - weight of evidence unknown/unassessed/unreview: published lit review or major tox study | Illinois EPA Chemicals Associated with Endocrine System |
| endocrine - weight of evidence unknown/unassessed/unreview: published lit review or major tox study | Our Stolen Future Endocrine Disruptors |
Developmental/reproductive toxicity
| Type of concern: | Reference: |
| Human nervous system toxicant - moderate evidence | Chemicals known to be neurotoxic to humans |
| Limited evidence of developmental toxicity | Agency for Toxic Substances and Disease Registry, 2004 |
| Limited evidence of reproductive toxicity | US EPA, 9204 |
Occupational hazards
| Type of concern: | Reference: |
| Allowed workplace exposures restricted to very low doses | RTECS®- TLV/BEI,2007 |
| Allowed workplace exposures restricted to low doses | European Union - Classification & Labelling |
Organ system toxicity (non-reproductive)
| Type of concern: | Reference: |
| Classified as toxic or harmful | European Union - Classification & Labelling |
| Limited evidence of gastrointestinal or liver toxicity | National Library of Medicine HazMap |
| Limited evidence of gastrointestinal or liver toxicity | Agency for Toxic Substances and Disease Registry, 2004 |
| Limited evidence of kidney toxicity | Merck & Co |
| One or more animal studies show classified as toxic effects at moderate doses (low dose studies may be unavailable for this ingredient) | National Library of Medicine HazMap |
Ecotoxicology
| Type of concern: | Reference: |
| Wildlife and environmental toxicity | European Union - Classification & Labelling |
| Wildlife and environmental toxicity | EPA Clean Water Act - Priority Pollutants |
| Wildlife and environmental toxicity | Illinois EPA Chemicals Associated with Endocrine System |
Government, industry, academic studies and classifications
| government/industry list/academic study | appears on list as | classification(s) |
| European Union - Classification & Labelling | ALDRIN | •Toxic •Toxic in contact with skin and ingestion •Limited evidence of a carcinogenic effect •Limited evidence of a carcinogenic effect •Dangerous for the environment •Very toxic to aquatic organisms |
| Amer Conf of Gov't Industrial Hygienists - Carcinogens | ALDRIN (HHDN) | •Confirmed animal carcinogen with unknown relevance to humans (ACGIH classification A3) |
| Association of Occupational and Environmental Clinics | ALDRIN | • P |
| EPA Clean Water Act - Priority Pollutants | ALDRIN | •Priority water pollutant under the Clean Water Act |
| Illinois EPA Chemicals Associated with Endocrine System | ALDRIN | •EPA: probable endocrine disruptor |
| EPA Integrated Risk Information System (IRIS) | ALDRIN | •Group B2: Probable human carcinogen - sufficient data in animals (EPA classification) |
| European Commission on Endocrine Disruption | ALDRIN | HH-CAT2;WF-CAT2 |
| European Union - Banned or Restricted in Cosmetics | ALDRIN | •Prohibited in EU cosmetics: must not form part of the composition of cosmetic products |
| National Library of Medicine HazMap | ALDRIN | •Skin Designation (ACGIH) - Danger of cutaneous absorption (ACGIH): Yes; •Restricted - Regulations that have banned or restricted the use of the agent: In 1974, EPA banned all uses except termite control. In 1987, EPA banned al uses. [ATSDR ToxFAQs]; •Hepatotoxin: Hepatotoxin, Secondary; •PEL (OSHA) - Permissible exposure limit (OSHA): 0.25 mg/m3; •Bioaccumulates: Yes; •Other Poison: Organochlorine Pesticide; •TLV (ACGIH) - Threshold limit value (ACGIH): 0.25 mg/m3; •IDLH (NIOSH) - Immediately Dangerous to Life or Health: 25 mg/m3; •MAK - Maximum Allowable Concentration (Federal Republic of Germany): 0.25 mg/m3; |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | ALDRIN | •IARC Group 3 (no cancer link) |
| NIOSH Occupational Carcinogens | ALDRIN | •Potential occupational carcinogen according to NIOSH (National Institute for Occupational Safety and Health) |
| Our Stolen Future Endocrine Disruptors | ALDRIN | • |
| Aarhus Protocol on Persistent Organic Pollutants | 1,2,3,4,10,10-HEXACHLORO-1,4,4A,5,8,8A-HEXAHYDRO-(1A,4A,4AB,5A,8A,8AB)-1,4:5,8-DIMETHANONAPHTHALENE | Banned under the Aahrus Protocol for Persistent Organic Pollutants |
| Great Lakes BTS (Binational Toxics Strategy) PBTs | 1,2,3,4,10,10-HEXACHLORO-1,4,4A,5,8,8A-HEXAHYDRO-(1A,4A,4AB,5A,8A,8AB)-1,4:5,8-DIMETHANONAPHTHALENE | •Persistent, bioaccumulative toxicant - Great Lakes Binational Strategy, Tier 1 concern (highest), targeted for phase-out |
| OSPAR PBTs - Substances of Possible Concern | 1,2,3,4,10,10-HEXACHLORO-1,4,4A,5,8,8A-HEXAHYDRO-(1A,4A,4AB,5A,8A,8AB)-1,4:5,8-DIMETHANONAPHTHALENE | •Persistent, bioaccumulative toxicant - Oslo-Paris (OSPAR) Convention for the Protection of the Marine Environment of the North-East Atlantic, chemical of concern |
| United Nations Environment Programme/POPs Treaty | 1,2,3,4,10,10-HEXACHLORO-1,4,4A,5,8,8A-HEXAHYDRO-(1A,4A,4AB,5A,8A,8AB)-1,4:5,8-DIMETHANONAPHTHALENE | •Persistent, bioaccumulative toxicant - targeted for restrictions under international treaty (Stockholm Convention on Persistent Organic Pollutants, or POPs Convention) |
| EPA Toxic Release Inventory PBTs | 1,2,3,4,10,10-HEXACHLORO-1,4,4A,5,8,8A-HEXAHYDRO-(1A,4A,4AB,5A,8A,8AB)-1,4:5,8-DIMETHANONAPHTHALENE | •Persistent, bioaccumulative toxicant - targeted for waste reporting under U.S. Environmental Protection Agency Toxics Release Inventory programs |
| California EPA Proposition 65 | ALDRIN | •Carcinogen: California Proposition 65 |
| Agency for Toxic Substances and Disease Registry, 2004 | ALDRIN | •Developmental toxicity hazards: suspected |
| Agency for Toxic Substances and Disease Registry, 2004 | ALDRIN | •Gastrointestinal or liver toxicity hazards: suspected |
| US EPA, 9204 | ALDRIN | •Reproductive toxicity hazards: suspected |
| Illinois EPA, 1997 | ALDRIN | •Endocrine toxicity hazards: suspected |
| Merck & Co | ALDRIN | •Kidney toxicity hazards: suspected |
| Proposition 65 List of Carcinogens | ALDRIN | •Cancer hazards: recognized |
| RTECS®- TLV/BEI,2007 | ALDRIN | • occupationally related - ACGIH TLV (human TWA) |
| RTECS®- Archives of Toxicology 1980 | ALDRIN | • mutagenic - Positive mutation assay: DNA Inhibition ( human lym) |
| RTECS®- Carcinogenesis (London) 1987 | ALDRIN | • mutagenic - Positive mutation assay: Unscheduled DNA Synthesis (mouse orl) |
| RTECS®- IRCS Medical Science 1986 | ALDRIN | • mutagenic - Positive mutation assay: Cytogenetic Analysis (mouse orl) |
| RTECS®- Mutation Research 1975 | ALDRIN | • mutagenic - Positive mutation assay: Cytogenetic Analysis ( human lym) |
| RTECS®- Mutation Research 1995 | ALDRIN | • mutagenic - Positive mutation assay: other mutation test systems (mouse orl) |
| RTECS®- Mutation Research 1977 | ALDRIN | • mutagenic - Positive mutation assay: Unscheduled DNA Synthesis ( human fbr) |
| RTECS®- Nucleus (Calcutta) 1985 | ALDRIN | • mutagenic - Positive mutation assay: Micronucleus test (other fish ipr) |
| RTECS®- Personal Communication from J 1982 | ALDRIN | • mutagenic - Positive mutation assay: DNA Damage (rat lvr) |
| RTECS®- Pharmacology and Therapeutics 1979 | ALDRIN | • mutagenic - Positive mutation assay: Cytogenetic Analysis (rat ipr) |
| RTECS®- Rivista di Scienza e Technologia degli Alimenti e di Nutrizione Umana 1976 | ALDRIN | • mutagenic - Positive mutation assay: Mutation in Micro-organism (Saccharomyces cerevisiae ) |
references
| government/industry list/academic study | reference |
| European Union - Classification & Labelling | CPS&Q (Consumer Products Safety & Quality) formely known as ECB (European Chemicals Bureau). 2008. Classification and Labelling: Chemicals: Annex VI of Directive 67/548/EEC through the 31st ATP. |
| Amer Conf of Gov't Industrial Hygienists - Carcinogens | ACGIH (American Conference of Governmental Industrial Hygienists) 2008. ACGIH cancer classification system. www.acgih.org. |
| Association of Occupational and Environmental Clinics | AOEC (Association of Occupational and Environmental Clinics). 2009. AEOC exposures codes and asthmagen designation. |
| EPA Clean Water Act - Priority Pollutants | |
| Illinois EPA Chemicals Associated with Endocrine System | Illinois EPA (Illinois Environmental Protection Agency). 2000. Preliminary list of chemicals associated with endocrine system effects in animals and humans (*) or in vitro (+). In EPA (U.S. Environmental Protection Agency) 2000. Handbook for Non-Cancer Health Effects Valuation, Appendix C. |
| EPA Integrated Risk Information System (IRIS) | EPA (U.S. Environmental Protection Agency). 2008. Integrated Risk Information System (IRIS). Evidence for human carcinogenicity based on 1986-2005 guidelines. |
| European Commission on Endocrine Disruption | EU (European Union)- Strategy for Endocrine Disrupters 2007. Commision on endocrin disruption requested by the European Parliament in 1998. |
| European Union - Banned or Restricted in Cosmetics | EC (European Commission of the European Union). 1999-2006. Enterprise Directorate-General Pharmaceuticals and Cosmetics. The rules governing cosmetic products in the European Union, Volume 1, "Cosmetics legislation." |
| National Library of Medicine HazMap | NLM (National Library of Medicine). 2006. HazMap — Occupational Exposure to Hazardous Agents. |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | IARC (International Agency for Research on Cancer). 2008. Overall Evaluations of Carcinogenicity to Humans, as evaluated in IARC Monographs Volumes 1-99 (a total of 935 agents, mixtures and exposures). |
| NIOSH Occupational Carcinogens | NIOSH (National Institute for Occupational Safety and Health). 2006. NIOSH Carcinogens List (Potential occupational carcinogens). http://www.cdc.gov/niosh/npotocca.html. |
| Our Stolen Future Endocrine Disruptors | Colborn T, D Dumanoski, JP Myers. 2006. Widespread Pollutants with Endocrine-disrupting Effects. Updated from original listing in "Our Stolen Future" (1996). |
| Aarhus Protocol on Persistent Organic Pollutants | Aarhus LRTAP. 1998. Aarhus Protocol on Persistent Organic Pollutants (POPs). Geneva Convention on Long-range Transboundary Air Pollution, United Nations Environment Program. |
| Great Lakes BTS (Binational Toxics Strategy) PBTs | Great Lakes BTS (Binational Toxics Strategy). 1997. Canada-United States Strategy for the Virtual Elimination of Persistent Toxic Substances in the Great Lakes. Appendix I - Level 1 and Level 2 substances. |
| OSPAR PBTs - Substances of Possible Concern | OSPAR (Oslo-Paris). 2002. OSPAR List of Substances of Possible Concern. Secondary OSPAR List of Substances of Possible Concern. Secondary OSPAR. Place Published, OSPAR Convention for the Protection of the Marine Environement of North-East Atlanic. |
| United Nations Environment Programme/POPs Treaty | UNEP (United Nations Environment Programme). 2001. Stockholm Convention on Persistent Organic Pollutants (POPs) — POPs Treaty. |
| EPA Toxic Release Inventory PBTs | EPA (U.S. Environmental Protection Agency). 1999. Toxics Release Inventory Program. PBT Chemical Rule. |
| California EPA Proposition 65 | California EPA (California Environmental Protection Agency). 9/2008. Office of Environmental Health Hazard Assessment. Safe Drinking Water and Toxic Enforcement Act of 1986. Chemicals known to the State to cause cancer or reproductive toxicity. |
| Scorecard.org Toxicity Information | Agency for Toxic Substances and Disease Registry. Minimal risk Levels for Hazardous Substances. January 2004. http://www.atsdr.cdc.gov/mrls.html, US EPA. Roadmaps to Sources of Information on Chemicals Listed in the Emergency Planning Community and Community Right-to-Know Act (Also Known as SARA Title 3), Section 313 Toxic Release Inventory (for Microcomputers). (Report Number EPADFDK92040). 1991. Data file distributed in 2 diskettes by Office of Pollution, Prevention, and Toxics, Environmental Protection Agency, Washington, DC. NOTE: Datasource no longer being maintained by EPA; not currently available online., Jankovic, J. A Screening Method for Occupational Reproductive Health Risk. American Industrial Hygiene Association Journal. 57: 641-649. 1996. |
| Scorecard.org Toxicity Information | Agency for Toxic Substances and Disease Registry. Minimal risk Levels for Hazardous Substances. January 2004. http://www.atsdr.cdc.gov/mrls.html, National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances. See Environmental Defense's Suspect Hazard Identification documentation. |
| Scorecard.org Toxicity Information | US EPA. Roadmaps to Sources of Information on Chemicals Listed in the Emergency Planning Community and Community Right-to-Know Act (Also Known as SARA Title 3), Section 313 Toxic Release Inventory (for Microcomputers). (Report Number EPADFDK92040). 1991. Data file distributed in 2 diskettes by Office of Pollution, Prevention, and Toxics, Environmental Protection Agency, Washington, DC. NOTE: Datasource no longer being maintained by EPA; not currently available online. |
| Scorecard.org Toxicity Information | Illinois EPA. Endocrine Disruptors Strategy. 1997. (Table 1: Preliminary List of Chemicals Associated with Endocrine System Effects in Animals and Humans or In Vitro). http://www.nihs.go.jp/hse/environ/illiepatable.htm, Japanese National Institute of Health Sciences. Lists of Paradigmatic Chemicals. http://www.nihs.go.jp/hse/endocrine-e/paradigm/paradigm.html |
| Scorecard.org Toxicity Information | Merck & Co. The Merck Manual of Diagnosis and Therapy. TABLE 226-1. Common Nephrotoxic Agents http://www.merck.com/pubs/mmanual/tables/226tb1.htm |
| Scorecard.org Toxicity Information | Proposition 65 List of Carcinogens (July 2004) can be obtained from http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html. |
| RTECS®- TLV/BEI,2007 | RTECS®- TLV/BEI,2007 |
| RTECS®- Archives of Toxicology 1980 | RTECS®- Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 45,101,1980 |
| RTECS®- Carcinogenesis (London) 1987 | RTECS®- Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 8,1433,1987 |
| RTECS®- IRCS Medical Science 1986 | RTECS®- IRCS Medical Science. (Lancaster, UK) V.12-14, 1984-86. For publisher information, see MSCREJ. 14,1125,1986 |
| RTECS®- Mutation Research 1975 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 31,103,1975 |
| RTECS®- Mutation Research 1995 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 343,157,1995 |
| RTECS®- Mutation Research 1977 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 42,161,1977 |
| RTECS®- Nucleus (Calcutta) 1985 | RTECS®- Nucleus (Calcutta). (Dr. A.K. Sharma, Centre of Advanced Studies in Cell and Chromosome Research, Calcutta, 35 Baliygunge Circular Rd., Calcutta 700 019, India) V.1- 28,176,1985 |
| RTECS®- Personal Communication from J 1982 | RTECS®- Personal Communication from J.F. Sina, Merck Institute for Therapeutic Research, West Point, PA 19486, Oct. 26, 1982 26OCT1982 |
| RTECS®- Pharmacology and Therapeutics 1979 | RTECS®- Pharmacology and Therapeutics. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.4- 6,147,1979 |
| RTECS®- Rivista di Scienza e Technologia degli Alimenti e di Nutrizione Umana 1976 | RTECS®- Rivista di Scienza e Technologia degli Alimenti e di Nutrizione Umana. Review of Science and Technology of Food and Human Nutrition. (Bologna, Italy) V.5-6, 1975-76. Discontinued. 6,161,1976 |
"RTECS®" is a United States trademark owned and licensed under authority of the U.S. Government, by and through MDL Information Systems, Inc.